Literature DB >> 15892597

Design and analysis of phase III trials with ordered outcome scales: the concept of the sliding dichotomy.

Gordon D Murray1, David Barer, Sung Choi, Helen Fernandes, Barbara Gregson, Kennedy R Lees, Andrew I R Maas, Anthony Marmarou, A David Mendelow, Ewout W Steyerberg, Gillian S Taylor, Graham M Teasdale, Christopher J Weir.   

Abstract

The conventional approach to the analysis of a Phase III trial in head injury or stroke takes an ordered scale measuring functional outcome and collapses the scale to a binary outcome of favorable versus unfavorable. This discards potentially relevant information which limits statistical power and moreover is not in accord with clinical practice. We propose an alternative approach where a favorable outcome is defined as better than would be expected, taking account of each individual patient's baseline prognosis. This is illustrated through a worked example based on data from a Phase III trial in head injury. The approach is also compared with the proportional odds model, which is another statistical approach that can exploit an ordered outcome scale. The approach raises issues of clinical, statistical, and regulatory importance, and we initiate what we believe needs to become a widespread debate amongst the community involved in clinical research in head injury and stroke.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15892597     DOI: 10.1089/neu.2005.22.511

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  46 in total

1.  Lessons from traumatic head injury for assessing functional status after brain tumour.

Authors:  J T Lindsay Wilson
Journal:  J Neurooncol       Date:  2012-02-11       Impact factor: 4.130

Review 2.  Issues in selecting outcome measures to assess functional recovery after stroke.

Authors:  Sharon Barak; Pamela W Duncan
Journal:  NeuroRx       Date:  2006-10

3.  What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2?

Authors:  N Weisscher; M Vermeulen; Y B Roos; R J de Haan
Journal:  J Neurol       Date:  2008-03-14       Impact factor: 4.849

4.  Prognostic modelling in traumatic brain injury.

Authors:  David Menon; David Harrison
Journal:  BMJ       Date:  2008-02-12

Review 5.  Clinical trial design in the neurocritical care unit.

Authors:  C E Hall; M Mirski; Y Y Palesch; M N Diringer; A I Qureshi; C S Robertson; R Geocadin; C A C Wijman; P D Le Roux; Jose I Suarez
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

6.  Regression analysis of ordinal stroke clinical trial outcomes: an application to the NINDS t-PA trial.

Authors:  Stacia M Desantis; Christos Lazaridis; Yuko Palesch; Viswanathan Ramakrishnan
Journal:  Int J Stroke       Date:  2013-06-27       Impact factor: 5.266

7.  Comparative study of outcome measures and analysis methods for traumatic brain injury trials.

Authors:  Aziz S Alali; Darcy Vavrek; Jason Barber; Sureyya Dikmen; Avery B Nathens; Nancy R Temkin
Journal:  J Neurotrauma       Date:  2015-02-09       Impact factor: 5.269

8.  Glasgow Outcome Scale Measures and Impact on Analysis and Results of a Randomized Clinical Trial of Severe Traumatic Brain Injury.

Authors:  Jose-Miguel Yamal; H Julia Hannay; Shankar Gopinath; Imoigele P Aisiku; Julia S Benoit; Claudia S Robertson
Journal:  J Neurotrauma       Date:  2019-05-23       Impact factor: 5.269

Review 9.  SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.

Authors:  R Loch Macdonald; Blessing Jaja; Michael D Cusimano; Nima Etminan; Daniel Hanggi; David Hasan; Don Ilodigwe; Hector Lantigua; Peter Le Roux; Benjamin Lo; Ada Louffat-Olivares; Stephan Mayer; Andrew Molyneux; Audrey Quinn; Tom A Schweizer; Thomas Schenk; Julian Spears; Michael Todd; James Torner; Mervyn D I Vergouwen; George K C Wong; Jeff Singh
Journal:  Transl Stroke Res       Date:  2013-01-07       Impact factor: 6.829

10.  Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Yeon Gyoe Jang; Don Ilodigwe; R Loch Macdonald
Journal:  Neurocrit Care       Date:  2008-09-23       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.